71 related articles for article (PubMed ID: 400370)
1. [Thrombocyte function and systemic effect of prostaglandin I2 inhalation].
Silberbauer K; Sinzinger H; Burghuber O; Elliott M; Leithner C; Schernthaner G
Acta Med Austriaca Suppl; 1979; 6():401-3. PubMed ID: 400370
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
[No Abstract] [Full Text] [Related]
3. The antiplatelet activity of immobilized prostacyclin.
Ebert CD; Lee ES; Kim SW
J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
[TBL] [Abstract][Full Text] [Related]
4. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
Kovács G; Simonidesz V; Tömösközi I; Körmöczy P; Székely I; Papp-Behr A; Stadler I; Szekeres L; Papp G
J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
[No Abstract] [Full Text] [Related]
5. Application of a new prostaglandin I2 analogue (APS-306) on cardiopulmonary bypass.
Takahama T; Kanai F; Iizuka I; Hiraishi M; Yamazaki Z; Idezuki Y; Sudo K; Asano K; Morioka M; Kazama M
Trans Am Soc Artif Intern Organs; 1984; 30():44-8. PubMed ID: 6398549
[No Abstract] [Full Text] [Related]
6. Effects of taprostene, a stable prostacyclin analogue, on haemodynamics, platelet function and arachidonate metabolism in healthy volunteers.
Virgolini I; Fitscha P; Sinzinger H; Barth H
Eur J Clin Pharmacol; 1990; 38(4):347-50. PubMed ID: 2111774
[TBL] [Abstract][Full Text] [Related]
7. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation].
Messini M; Messini F
Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908
[No Abstract] [Full Text] [Related]
8. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
[No Abstract] [Full Text] [Related]
9. [Mechanism of action of different inhibitors of thrombocyte aggregation].
Lakin KM; Makarov VA; Novikova NV; Muliar AG
Vestn Akad Med Nauk SSSR; 1984; (11):54-63. PubMed ID: 6099015
[No Abstract] [Full Text] [Related]
10. Prostacyclin-synthesis stimulating plasma factor and platelet sensitivity in preeclampsia.
Dadak C; Kefalides A; Sinzinger H
Biol Res Pregnancy Perinatol; 1985; 6(2):65-9. PubMed ID: 3893552
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
Nakagawa S; Matsui N; Akiba T; Shinoda T; Fukudome Y; Ozawa K; Baba M; Nakanishi T; Takeuchi J
Proc Eur Dial Transplant Assoc; 1981; 18():117-21. PubMed ID: 7036145
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of prostaglandin I2 and its derivative in extracorporeal circulation].
Takeda H; Matsukura H; Kawakami T; Tanabe T
Kyobu Geka; 1983 Jun; 36(6):479-84. PubMed ID: 6355587
[No Abstract] [Full Text] [Related]
13. Delayed antiischemic effect of prostaglandin I2 and of a new stable prostaglandin I2 analogue, 7-oxo-prostacyclin-Na, in experimental model angina in dogs.
Szekeres L; Krassói I; Pataricza J; Udvary E
Adv Myocardiol; 1985; 6():607-18. PubMed ID: 3887531
[TBL] [Abstract][Full Text] [Related]
14. Effect of beraprost sodium, a stable prostaglandin I2 analogue, on platelet aggregation in diabetes mellitus.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pharmacol Res; 1996; 16(4-5):99-102. PubMed ID: 9172007
[TBL] [Abstract][Full Text] [Related]
15. Effects of synthetic prostaglandin analogues on platelet aggregation and secretion [proceedings].
Corey EJ; Gordon JL; MacIntyre DE; Salzman EW
Br J Pharmacol; 1977 Mar; 59(3):446P-447P. PubMed ID: 843695
[No Abstract] [Full Text] [Related]
16. Hemolytic-uremic syndrome: demonstration of abnormalities of platelet reactivity and insensitivity to prostaglandin I2.
Bloom A; Hannaford PA; Greaves M; Preston FE; Brown CB
Clin Nephrol; 1985 Feb; 23(2):85-8. PubMed ID: 3886228
[TBL] [Abstract][Full Text] [Related]
17. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
[No Abstract] [Full Text] [Related]
18. 11- and 15-deoxy-carboprostacyclins: hypothetic prostacyclin antagonists.
Mongelli N; Magni O; Gandolfi C; Grossoni M; Ceserani R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():281-5. PubMed ID: 6221538
[No Abstract] [Full Text] [Related]
19. Aggregation of platelets induced by novel synthetic secoprostaglandins.
Ohtsu A; Tanaka T; Kamimoto F; Okamiya Y; Hoshina K; Kurozumi S; Naruchi T
J Pharmacobiodyn; 1981 Oct; 4(10):771-8. PubMed ID: 7033497
[TBL] [Abstract][Full Text] [Related]
20. [Respiratory effects of PGI-2 in the pig].
Clement MG; Maggi GC; Triulzi MO
Boll Soc Ital Biol Sper; 1979 Oct; 55(20):2095-9. PubMed ID: 398215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
